Literature DB >> 2822437

A binding site for [3H]glipizide in the rat cerebral cortex.

B Lupo1, D Bataille.   

Abstract

[3H]glipizide, a 2nd generation hypoglycemic sulfonylurea, binds specifically to rat cerebral cortex membranes in a time- and temperature-dependent way. The binding is saturable and reversible. The maximal binding capacity is 110 fmol/mg protein and the dissociation constant 1.5 nM. The binding site was destroyed by proteolytic and lipolytic enzymes suggesting a lipoprotein nature. Active analogs of sulfonylureas are characterized by IC50 values in the cerebral cortex which parallel their insulinotropic activity. In the cerebral cortex, adenylate cyclase was not stimulated by glipizide but sulfonylureas could inhibit, at high doses, the cAMP-dependent phosphodiesterase. This central binding site for glipizide displays the characteristics of the recognition moiety of a biological receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822437     DOI: 10.1016/0014-2999(87)90801-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Pharmacology and regulation of ATP-sensitive K+ channels.

Authors:  J R de Weille; M Fosset; C Mourre; H Schmid-Antomarchi; H Bernardi; M Lazdunski
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

2.  The beta-cell glibenclamide receptor is an ADP-binding protein.

Authors:  I Niki; J L Nicks; S J Ashcroft
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

3.  Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain.

Authors:  A Virsolvy-Vergine; H Leray; S Kuroki; B Lupo; M Dufour; D Bataille
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels.

Authors:  M L Ashford; P R Boden; J M Treherne
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding.

Authors:  I Niki; R P Kelly; S J Ashcroft; F M Ashcroft
Journal:  Pflugers Arch       Date:  1989-10       Impact factor: 3.657

6.  Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.

Authors:  H Xu; K M Williams; W S Liauw; M Murray; R O Day; A J McLachlan
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

7.  Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.

Authors:  M Schwanstecher; C Brandt; S Behrends; U Schaupp; U Panten
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15.

Authors:  I Niki; M Welsh; P O Berggren; P Hubbard; S J Ashcroft
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

9.  Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties.

Authors:  L Heron; A Virsolvy; K Peyrollier; F M Gribble; A Le Cam; F M Ashcroft; D Bataille
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel.

Authors:  H Bernardi; M Fosset; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.